Virology & Mycology Infectious Diseases
» Journals
A
Accounting & Marketing
Addiction Research & Therapy
Advances in Automobile Engineering
Advances in Crop Science and Technology
Advances in Dairy Research
Advancements in Genetic Engineering
Advances in Pharmacoepidemiology & Drug Safety
Advances in Robotics & Automation
Advance Research in Meteorological Sciences
Advanced Techniques in Biology & Medicine
Aeronautics & Aerospace Engineering
Aging Science
Agrotechnology
AIDS & Clinical Research
Allergy & Therapy
Alternative & Integrative Medicine
Air & Water borne Diseases
Alcoholism and Drug Dependence
Alzheimer’s Disease & Parkinsonism
Analytical & Bioanalytical Techniques
Anaplastology
Anatomy & Physiology
Andrology-Open Access
Anesthesia & Clinical Research
Angiology: Open Access
Antivirals & Antiretrovirals
Anthropology
Applied & Computational Mathematics
Applied Mechanical Engineering
Aquaculture Research & Development
Architectural Engineering Technology
Arthritis
Arts and Social Sciences Journal
Astrobiology & Outreach
Astrophysics & Aerospace technology
Autacoids
Autism-Open Access

B
Bacteriology & Parasitology
Bioanalysis & Biomedicine
Bioceramics Development and Applications
Biochemistry and Analytical Biochemistry
Biochemistry & Pharmacology
Biochips & Tissue Chips
Biodiversity & Endangered Species
Bioenergetics: Open Access
Bioengineering & Biomedical Science
Bioequivalence & Bioavailability
Biofertilizers & Biopesticides
Biological Systems-Open Access
Biology and Medicine
Biometrics & Biostatistics
Biomolecular Research & Therapeutics
Biochemistry & Physiology: Open Access
Bioprocessing & Biotechniques
Bioremediation & Biodegradation
Biosafety
Biosafety & Health Education
Biosensors & Bioelectronics
Biotechnology & Biomaterials
Bioterrorism & Biodefense
Blood Disorders & Transfusion
Blood & Lymph
Bone Marrow Research
Brain Disorders & Therapy
Business and Economics Journal
Business and Financial Affairs

C
Cancer Science & Therapy
Carcinogenesis & Mutagenesis
Cardiovascular Diseases & Diagnosis
Cardiovascular Pharmacology: Open Access
Cell & Developmental Biology
Cell Science & Therapy
Chemical Engineering & Process Technology
Chemical Sciences Journal
Chemotherapy: Open Access
Child and Adolescent Behavior
Chromatography & Separation Techniques
Civil & Environmental Engineering
Civil & Legal Sciences
Clinical & Cellular Immunology
Clinical Case Reports
Clinical & Experimental Cardiology
Clinical & Experimental Dermatology Research
Clinical & Experimental Ophthalmology
Clinical & Experimental Pathology
Clinical & Experimental Pharmacology
Clinical Pharmacology & Biopharmaceutics
Clinical Research & Bioethics
Clinical Research on Foot & Ankle
Clinical Toxicology
Clinical Trials
Clinical Microbiology: Open Access
Cloning  & Transgenesis
Communication Disorders, Deaf Studies & Hearing Aids
Community Medicine & Health Education
Computer Science & Systems Biology
Current Synthetic & Systems Biology
Cytology & Histology
D
Data Mining in Genomics & Proteomics
Defense Management
Dentistry
Depression and Anxiety
Developing Drugs
Diabetes & Metabolism
Drug Designing
Drug Metabolism & Toxicology

E
Earth Science & Climatic Change
Ecosystem & Ecography
Endocrinology & Metabolic Syndrome
Entomology, Ornithology & Herpetology
Environmental & Analytical Toxicology
Epidemiology: Open Access
Emergency Medicine: Open Access
Ergonomics
Electrical & Electronics
Enzyme Engineering
Entrepreneurship & Organization Management

F
Family Medicine & Medical Science Research
Fermentation Technology
Fertilization: In Vitro - IVF-Worldwide
Fisheries and Aquaculture Journal
Fisheries & Livestock Production
Food Processing & Technology
Forensic Research
Forest Research: Open Access

G
Gastrointestinal & Digestive System
Genetic Syndromes & Gene Therapy
General Medicine
Gene Technology
Geography & Natural Disasters
Geology & Geosciences
Geophysics & Remote Sensing
Gerontology & Geriatric Research
Global Economics
Glycobiology
Glycomics & Lipidomics
Gynecology& Obstetrics

H
Hematology & Thromboembolic Diseases
Hair : Therapy & Transplantation
Health & Medical Informatics
Hereditary Genetics
Homeopathy & Ayurvedic Medicine
Horticulture
Hotel & Business Management
Human Genetics & Embryology
Hydrology: Current Research
Hypertension- Open Access

I
Industrial Engineering & Management
Irrigation and Drainage Systems Engineering
Information Technology & Software Engineering
Intellectual Property Rights: Open Access
Infectious Diseases and Therapy
Integrative Oncology
Internal Medicine
International Journal of Advance Innovations, Thoughts & Ideas
International Journal of Economics & Management Sciences
International Journal of Genomic Medicine
International Journal of Physical Medicine & Rehabilitation

L
Liver
Leukemia

M
Marine Science: Research & Development
Mass Communication & Journalism
Material Sciences & Engineering
Medicinal Chemistry
Medicinal & Aromatic Plants
Medical Diganostic Methods
Medical Microbiology & Diagnosis
Medical & Surgical Urology
Membrane Science & Technology
Metabolic Syndrome
Metabolomics:Open Access
Microbial & Biochemical Technology
Molecular Biology
Molecular Biomarkers & Diagnosis
Molecular and Genetic Medicine
Molecular Imaging & Dynamics
Modern Chemistry & Applications
Mycobacterial Diseases
N
Nanomedicine & Biotherapeutic Discovery
Nanomedicine & Nanotechnology
Natural Products Chemistry & Research
Neonatal Biology
Nephrology & Therapeutics
Neurology & Neurophysiology
Novel Physiotherapies
Nuclear Medicine & Radiation Therapy
Neurological Disorders
Nutrition & Food Sciences
Nutritional Disorders & Therapy
Nursing & Care

0
Obesity & Weight Loss Therapy
Occupational Medicine & Health Affairs
Oceanography-Open Access
OMICS Journal of Radiology
Osteoporosis and Physical Activity
Oral Health and Dental Management
Oral Hygiene & Health
Biological Systems- Open Access
Organic Chemistry: Current Research
Orthopedic & Muscular System: Current Research
Otolaryngology

P
Pain & Relief 
Palliative Care  & Medicine
Pancreatic Disorders & Therapy
Pediatrics & Therapeutics
Petroleum & Environmental Biotechnology
Pharmaceutica Analytica Acta
Pharmaceutical Regulatory Affairs: Open Access
Pharmacovigilance
Pharmacogenomics & Pharmacoproteomics
Physical Chemistry & Biophysics
Plant Pathology & Microbiology
Plant Biochemistry & Physiology
political Sciences & public affairs
Pollution Effects & Control
Poultry, Fisheries & Wildlife Sciences
Powder Metallurgy & Mining
Primatology
Primary Health Care: Open Access  
Probiotics & Health
Proteomics & Bioinformatics
Phylogenetics & Evolutionary Biology
Psychology & Psychotherapy
Psychological Abnormalities in Children
Pulmonary & Respiratory Medicine

R
Reproductive System & Sexual Disorders
Rheumatology: Current Research
Rice Research: Open Access

S
Sleep Disorders & Therapy
Socialomics
Sports Medicine & Doping Studies
Spine
Stem Cell Research & Therapy
Steroids & Hormonal Science
Stock & Forex Trading
Single Cell Biology
Sociology and Criminology-Open Access
Surgery: Current Research

T
Telecommunications System & Management
Textile Science & Engineering
Theoretical and Computational Chemistry: Open Access
Thermodynamics & Catalysis
Thyroid Disorders & Therapy
Tissue Science & Engineering
Translational Medicine
Transplantation Technologies & Research
Trauma & Treatment
Tropical Medicine and Surgery
Tourism & Hospitality

V
Vaccines & Vaccination
Vascular Medicine & surgery
Veterinary Science & Technology
Virology & Mycology
Vitamins & Minerals

W
Women's health Care

Y
Yoga & Physical Therapy
» Browse by Subjects
Clinical
AIDS & Clinical Research
Anesthesia & Clinical Research
Angiology
Cancer Science & Therapy
Carcinogenesis & Mutagenesis
Cell Science & Therapy
Chemotherapy
Child & Adolescent Behavior
Clinical & Cellular Immunology
Clinical Case Reports
Clinical & Experimental Cardiology
Clinical & Experimental Dermatology Research
Clinical & Experimental Ophthalmology
Clinical & Experimental Pharmacology
Clinical & Experimental Pathology
Clinical Microbiology: Open Access
Clinical Research & Bioethics
Clinical Research on Foot & Ankle
Clinical Toxicology
Clinical Trials
Communication Disorders, Deaf Studies & Hearing Aids
Cytology & Histology
Forensic Research
Integrative Oncology
Neurology & Neurophysiology
Pulmonary & Respiratory Medicine
Stem Cell Research & Therapy
Transplantation Technologies & Research

Pharmaceutical Sciences
Advances in Pharmacoepidemiology & Drug Safety
Alcoholism and Drug Dependence
Bioanalysis & Biomedicine
Biochemical Pharmacology
Bioequivalence & Bioavailability
Cardiovascular Pharmacology: Open Access
Clinical Pharmacology & Biopharmaceutics
Developing Drugs
Drug Designing
Drug Metabolism & Toxicology
Medicinal & Aromatic Plants
Molecular Pharmaceutics & Organic Process Research
Pharmaceutica Analytica Acta
Pharmaceutical Regulatory Affairs: Open Access
Pharmacovigilance
Vaccines & Vaccination

Omics
Data Mining in Genomics & Proteomics
Ergonomics
Glycomics & Lipidomics
Health & Medical Informatics
Metabolomics:Open Access
OMICS Journal of Radiology
Pharmacogenomics & Pharmacoproteomics
Phylogenetics & Evolutionary Biology
Proteomics & Bioinformatics
Transcriptomics

Chemistry
Analytical & Bioanalytical Techniques
Chemical Sciences Journal
Chromatography & Separation Techniques
Medicinal Chemistry
Modern Chemistry & Applications
Natural Products Chemistry & Research
Organic Chemistry
Physical Chemistry & Biophysics
Plant Biochemistry & Physiology
Thermodynamics & Catalysis
Theoretical and Computational Chemistry:Open Access

Environmental
Advance Research in Meteorological Sciences
Anthropology
Aquaculture Research & Development
Astrobiology & Outreach
Biodiversity & Endangered Species
Earth Science & Climatic Change
Ecosystem & Ecography
Environmental & Analytical Toxicology
Fisheries & Livestock Production
Geography & Natural Disasters
Hydrology: Current Research
Oceanography-Open Access
Petroleum & Environmental Biotechnology
Pollution Effects & Control
Poultry, Fisheries & Wildlife Sciences

Management
Accounting & Marketing
Arts and Social Sciences Journal
Business and Economics Journal
Business and Financial Affairs
Civil & Legal Sciences
Defense Management
Entrepreneurship& Organization Management
Hotel & Business Management
Intellectual Property Rights: Open Access
International Journal of Economics & Management Sciences
Mass Communication & Journalism
political Sciences & public affairs
Stock & Forex Trading
Socialomics
Tourism & Hospitality

Life  Sciences
Advanced Techniques in Biology & Medicine
Advancements in Genetic Engineering
Advances in Crop Science & Technology
Advances in Dairy Research
Aging Science
Agrotechnology
Air & Water Borne Diseases
Antivirals & Antiretrovirals
Autism-Open Access
Bacteriology & Parasitology
Biochemistry & Physiology: Open Access
Biochemistry and Analytical Biochemistry
Bioenergetics
Bioengineering & Biomedical Science
Biofertilizers & Biopesticides
Biological Systems- Open Access
Biometrics & Biostatistics
Biomolecular Research & Therapeutics
Bioremediation & Biodegradation
Biosafety
Biosafety & Health Education
Biosensors & Bioelectronics
Biotechnology & Biomaterials
Bioterrorism & Biodefense
Cell & Developmental Biology
Current Synthetic & Systems Biology
Entomology, Ornithology & Herpetology
Enzyme Engineering
Fermentation Technology
Fertilization: In Vitro - IVF-Worldwide
Fisheries and Aquaculture Journal
Forest Research: Open Access
Fungal Genomics and Biology
Gene Technology
Glycobiology
Horticulture
Homeopathy & Ayurvedic Medicine
Marine Science: Research & Development
Membrane Science & Technology
Microbial & Biochemical Technology
Molecular Biology
Molecular Imaging & Dynamics
Nanomedicine & Biotherapeutic Discovery
Nanomedicine & Nanotechnology
Nutrition & Food Sciences
Plant Pathology & Microbiology
Primatology
Probiotics & Health
Rice Research: Open Access
Single Cell Biology
Sociology and Criminology-Open Access
Tissue Science & Engineering
Tropical Diseases
Transcriptomics: Open Access
Veterinary Science & Technology
Vitamins & Minerals
Virology & Mycology

Engineering
Advances in Automobile Engineering
Advances in Robotics & Automation
Aeronautics & Aerospace Engineering
Applied & Computational Mathematics
Applied Mechanical Engineering
Architectural Engineering Technology
Astrophysics & Aerospace technology
Biochips & Tissue Chips
Bioprocessing & Biotechniques
Chemical Engineering & Process Technology
Civil & Environmental Engineering
Computer Science & Systems Biology
Electrical & Electronics
Food Processing & Technology
Geology and Geosciences
Geophysics & Remote sensing
Industrial Engineering & Management
Information Technology & Software Engineering
International Journal of Advance Innovations, Thoughts & Ideas
Irrigation and Drainage Systems Engineering
Material Sciences & Engineering
Powder Metallurgy & Mining
Telecommunications System & Management
Textile Science & Engineering

Medical Sciences
Addiction Research & Therapy
Allergy & Therapy
Alternative & Integrative Medicine
Alzheimer’s Disease & Parkinsonism
Anaplastology
Anatomy & Physiology
Ancient Diseases & Preventive Remedies
Andrology
Arthritis
Autacoids
Bioceramics Development and Applications
Biology and Medicine
Blood & Lymph
Blood Disorders & Transfusion
Bone Marrow Research
Brain Disorders & Therapy
Cardiovascular Diseases & Diagnosis
Cloning & Transgenesis
Community Medicine & Health Education
Dentistry
Depression and Anxiety
Diabetes & Metabolism
Emergency Medicine
Endocrinology & Metabolic Syndrome
Epidemiology: Open Access
Family Medicine & Medical Science Research
Gastrointestinal & Digestive System
General Medicine
General Practice
Genetic Syndromes & Gene Therapy
Gynecology& Obstetrics
Global Economics
Gerontology & Geriatrics Research
Hematology & Thromboembolic Diseases
Hair: Therapy & Transplantation
Health Care : Current Reviews
Hereditary Genetics
Human Genetics & Embryology
Hypertension-Open Access
International Journal of Genomic Medicine
Internal Medicine
International Journal of Physical Medicine & Rehabilitation
Leukemia
Liver
Medical & Surgical Urology
Medical Diagnostic Methods
Medical Microbiology & Diagnosis
Metabolic Syndrome
Molecular Biology
Molecular Biomarkers & Diagnosis
Molecular and Genetic Medicine
Mycobacterial Diseases
Neonatal Biology
Nephrology & Therapeutics
Neurological Disorders
Novel Physiotherapies
Nuclear Medicine & Radiation Therapy
Nursing & Care
Nutritional Disorders & Therapy
Obesity & Weight Loss Therapy
Occupational Medicine & Health Affairs
Oral Health and Dental Management
Oral Hygiene & Health
Orthopedic & Muscular System
Osteoporosis & Physical Activity
Otolaryngology
Pain & Relief
Palliative Care & Medicine
Pancreatic Disorders & Therapy
Pediatrics & Therapeutics
Primary Health Care: Open Access
Psychological Abnormalities in Children
Psychology & Psychotherapy
Reproductive System & Sexual Disorders
Rheumatology: Current Research
Sleep Disorders & Therapy
Spine
Sports Medicine & Doping Studies
Steroids & Hormonal Science
Surgery: Current Research
Thyroid Disorders & Therapy
Translational Medicine
Trauma & Treatment
Tropical Medicine and Surgery
Vascular Medicine & surgery
Women's Health Care
Yoga & Physical Therapy
» Conferences
 
Upcoming Conferences

2nd International Conference and Exhibition on Pathology, August 05-07, 2013 Las Vegas, USA

International Conference on Integrative Biology Summit, August 05-07, 2013 Las Vegas, USA

2ndInternational Conference on Translational Medicine, August 05-07, 2013 Chicago, USA


International Conference and Exhibition on Predictive, Preventive and Personalized Medicine & Molecular Diagnostics, August 05-07, 2013 Chicago, USA
2nd International Conference on Biodiversity & Sustainable Energy Development, August 12-14, 2013 Raleigh, USA

International Conference on Genetic Engineering & Genetically Modified Organisms, August 12-14, 2013 Raleigh, USA

4th World Congress on Diabetes & Metabolism, August 14-16, 2013 Chicago, USA

International Conference on Radiology and Imaging, August 14-16, 2013 Chicago, USA

2nd International Conference and Exhibition on Orthopedics & Rheumatology, August 19-21, 2013 Las Vegas, USA

International Conference on Dental & Oral Health, August 19-21, 2013 Las Vegas, USA

International Conference and Exhibition on Physical Medicine & Rehabilitation, August 19-21, 2013 Las Vegas, USA

International Conference on Molecular Epidemiology and Evolutionary Genetics, August 21-23, 2013 Miami, USA

International Conference on Oceanography, August 21-23, 2013 Orlando, USA

International Conference on Biodefense & Natural Disasters, August 21-23, 2013 Miami, USA

World Congress on Endocrinology, August 26-28, 2013 Raleigh, USA

2nd International Conference on Hydrology and Groundwater Expo, August 26-27, 2013 Raleigh, USA

2nd International Conference on Tissue Science & Regenerative Medicine, August 26-28, 2013 Raleigh, USA

International Conference on Omics Studies, September 04-06, 2013 Orlando-FL, USA

International Symposia on Entomology , September 04-06, 2013 Miami, USA

2nd International Conference on Surgery & Anesthesia, September 16-18, 2013 Las Vegas, USA

2nd International Conference on Clinical Microbiology & Microbial Genomics , September 16-18, 2013 Las Vegas, USA

2nd International Conference and Exhibition on Biowaivers & Biosimilars, September 23-25, 2013 Raleigh, USA

4th World Congress on Biotechnology, September 23-25, 2013 Raliegh, USA

International Conference on Hematology & Blood Disorders, September 23-25, 2013 Raliegh, USA

International Conference on Psychology, Autism and Alzheimer's Disease, September 30-October 01, 2013 San Antonio, USA

International Conference and Exhibition on Mechanical & Aerospace Engineering, September 30-October 02, 2013 San Antonio, USA

2nd International Summit on Toxicology, October 07-09, 2013 Las Vegas, USA

International Conference and Exhibition on Biochemical & Molecular Engineering, October 07-09, 2013 San Antonio, USA

International Conference and Exhibition on Lasers, Optics & Photonics, October 07-09, 2013 San Antonio, USA

2nd International Conference and Exhibition on Materials Science & Engineering, October 07-09, 2013 Las Vegas, USA

2nd International Conference on Forensic Research & Technology, October 07-09, 2013 Las Vegas, USA

2nd International Conference on Clinical & Cellular Immunology, October 15-17, 2013 Las Vegas, USA

2nd International Conference on Medicinal Chemistry & Computer Aided Drug Designing, October 15-17, 2013 Las Vegas, USA

4th International Conference and Exhibition on Analytical & Bioanalytical Techniques, October 15-17, 2013 Las Vegas, USA

International Conference and Exhibition on Pharmacognosy, Phytochemistry and Natural Products, October 21-23, 2013 Hyderabad, India

3rd World Congress on Cancer Science & Therapy, October 21-23, 2013 California, USA

3rd International Conference on Pharmaceutical Regulatory Affairs, October 21-23, 2013 California, USA

2nd International Conference and Exhibition on Cell & Gene Therapy October 23-25, 2013 Orlando, USA

2nd International Conference and Exhibition on Probiotics & Functional Foods, October 23-25, 2013 Orlando, USA

International Conference on HIV/AIDS, STDs, & STIs October 24-25, 2013 Orlando-FL, USA

International Conference on Fermentation Technology, Bioprocess and Cell Culture, October 28-30, 2013 Kansas City, USA

2nd International Conference and Exhibition on Food Processing & Technology, October 28-30, 2013 Kansas City, USA

International Conference on Functional and Comparative Genomics & Pharmacogenomics, November 12-14, 2013 Chicago, USA

2nd International Conference and Exhibition on Cosmetology & Trichology, November 12-14, 2013 Chicago, USA

2nd International Summit on GMP, QA & QC, November 12-14, 2013 Chicago, USA

2nd International Summit on GLP, GCP & Clinical Pharmacology, November 12-14, 2013 Chicago, USA

2nd International Conference and Exhibition on Pharmacovigilance & Clinical Trials, November 18-19, 2013 San Antonio, USA

International Summit on Clinical Pharmacy & Dispensing, November 18-20, 2013 San Antonio, USA

World Congress on Petrochemistry and Chemical Engineering, November 18-20, 2013 San Antonio, USA

3rd World Congress on Virology, November 20-22, 2013 Baltimore, USA

International Congress on Bacteriology and Infectious diseases, November 20-22, 2013 Baltimore, USA

3rd World Congress on Cell Science & Stem Cell Research, November 20-22, 2013 San Antonio, USA

2nd International Conference and Exhibition on Obesity & Weight Management, December 02-04, 2013 Las Vegas, USA

International Conference on Nursing & Emergency Medicine, December 02-04, 2013 Las Vegas, USA

3rd International Conference on Nanotek & Expo, December 02-04, 2013 Las Vegas, USA

International Conference and Exhibition on Traditional & Alternative Medicine, December 09-11, 2013 Hyderabad, India

2nd International Conference on Agricultural & Horticultural Sciences, February 03-05, 2014 Hyderabad, India





Previous Conferences Organized/Co-organized
2nd International Conference on Nephrology & Therapeutics, July 29-31, 2013 Las Vegas, USA
3rd International Conference on Vaccines & Vaccination, July 29-31, 2013 Las Vegas, USA

2nd International Conference on Earth Science & Climate Change, July 22-24, 2013 Las Vegas, USA

2nd International Conference and Exhibition on Addiction Research & Therapy, July 22-24, 2013 Las Vegas, USA

International Conference on Animal & Dairy Sciences, July 23-24, 2013 Las Vegas, USA

3rd International Conference on Proteomics & Bioinformatics, July 15-17, 2013 Philadelphia Center City, USA

2nd International Conference and Exhibition on Nutritional Science & Therapy, July 15-17, 2013 Philadelphia, USA

4th International Conference on Biomarkers & Clinical Research, July 15-17, 2013 Philadelphia, USA


2nd International Conference and Exhibition on Biosensors & Bioelectronics, June 17-19, 2013 Chicago, USA

2nd International Conference and Exhibition on Neurology & Therapeutics, June 17-19, 2013 Chicago, USA

2nd International Conference on Gastroenterology & Urology, June 10-12, 2013 Chicago, USA

2nd International Conference and Exhibition on Biometrics & Biostatistics, June 10-12, 2013 Chicago, USA

2nd International Conference and Exhibition on Occupational Health & Safety, May 21-22, 2013 Beijing, China

4th World Congress on Bioavailability & Bioequivalence, May 20-22, 2013 Beijing, China

3rd International Conference on Clinical & Experimental Ophthalmology, April 15-17, 2013 Chicago, USA

3rd International Conference on Clinical & Experimental Cardiology, April 15-17, 2013 Chicago, USA

3rd International Conference on Clinical & Experimental Dermatology, April 15-17, 2013 Chicago, USA

2ndInternational Conference and Exhibition on Metabolomics & Systems Biology, April 08-10, 2013 Chicago, USA

3rd International Conference and Exhibition on Pharmaceutics & Novel Drug Delivery Systems, April 08-10, 2013 Chicago, USA

International Exhibition and Conference on Water Technologies, Environmental Technologies & Renewable Energy, February 13-14, 2013 Mumbai, India

International Conference and Exhibition on Obesity and Weight Management, December 03-05, 2012 DoubleTree by Hilton Philadelphia, USA

International Summit on GMP & GCP: USA, Europe, Japan, Asia Pacific, December 03-05, 2012 DoubleTree by Hilton Philadelphia Center City, USA

International Conference on QA, QC and Validation, December 03-05, 2013 DoubleTree by Hilton Philadelphia Center City, USA

2nd International Conference on Nanotek and Expo, December 03-05, 2012 at DoubleTree by Hilton Philadelphia Center City, USA

International Conference on Hair Transplantation & Trichology November 26-28, 2012 San Antonio, USA

International Conference on Anesthesia & Perioperative Care November 26-28, 2012 San Antonio, USA

International Toxicology Summit & Expo November 26-28, 2012 Hilton San Antonio Airport, USA

International Conference and Exhibition on Surgery & Transplantation November 26-28, 2012 San Antonio, USA

International Conference and Exhibition on Food Processing and Technology November 22-24, 2012 Hyderabad, India

3rd International Conference and Exhibition on Analytical & Bioanalytical Techniques November 22-24, 2012 Hyderabad International Convention Center, India

2ndInternational Conference and Exhibition on Pharmaceutical Regulatory Affairs November 23-24, 2012 HICC Hyderabad, India

International Conference and Exhibition on Cosmetology & Cosmetics November 23-24, 2012 HICC Hyderabad, India

Global Biofuels and Bioproducts Summit November 19-21, 2012 San Antonio, USA

International Conference on Genetic Syndromes & GeneTherapy November 19-21, 2012 at Hilton San Antonio Airport, USA

International Conference and Exhibition on Probiotics-2012, November 19–21, 2012, Hilton San Antonio Airport, USA

2nd World Congress on Cell Science & Stem Cell Research November 12-14, 2012 San Antonio, USA

International Conference on Clinical Microbiology & Microbial Genomics November12-14, 2012 San Antonio, USA

International Conference on Regenerative and Functional Medicine November 12-14, 2012 San Antonio, USA

International Conference and Exhibition on Computer Aided Drug Design & QSAR October 29-31, 2012 Chicago, USA
International Conference on Pulmonary & Respiratory Medicine August 27-29, 2012 Philadelphia, USA.

International Expo & Conference on Analytrix & HPLC October 22-24, 2012 Hilton Northbrook, Chicago, USA

International Conference and Expo on Material science and Engineering October 22-24, 2012 DoubleTree by Hilton Chicago-North Shore, USA

International Conference on Clinical and Cellular Immunology October 22-24, 2012 DoubleTree by Hilton Chicago-North Shore, USA

International Conference on Forensic Research & Technology October 15-17, 2012 DoubleTree by Hilton Chicago-North Shore, USA

International Conference and Exhibition on Otolaryngology October 15-17, 2012 DoubleTree by Hilton Chicago-North Shore, USA

International conference on Biothreats and Biodefense October 15-17, 2012 DoubleTree by Hilton Chicago-North Shore, USA

International Conference on Tissue Science and Engineering October 1-3, 2012 DoubleTree by Hilton Chicago-North Shore, USA

International conference and Exhibition on Pharmacovigilance and Clinical Trials October 1-3, 2012 DoubleTree by Hilton Chicago-North Shore, USA

International Conference on Emerging Cell Therapies October 1-3, 2012 DoubleTree by Hilton Chicago-North Shore, USA

Omics International Integrative Biology summit October 1-3, 2012 DoubleTree by Hilton Chicago-North Shore, USA

3rdWorld Congress on Diabetes & Metabolism September 24-26, 2012 Marriott Convention Center, Hyderabad, India

2ndInternational Conference on Pediatrics & Gynecology September 24-26, 2012, Hyderabad Marriott Hotel & Convention Centre , Hyderabad, India

International Conference on Translational medicine September 17-19,2012 Holiday Inn San Antonio, Texas, USA

3rd World Congress on Biotechnology September 13-15, 2012 HICC, Hyderabad, India

International Conference on Biodiversity & Sustainable Energy Development September 14-15, 2012 Hyderabad, India

International Conference on Hotel and Business Management September 14-15, 2012 Hyderabad International Convention Center, India

International Conference on Agricultural & Horticultural Sciences September 14-15, 2012 Hyderabad International Convention Center, India

International Conference on Hydrology and Groundwater Expo September 10-12, 2012 San Antonio, USA

2nd World Congress on Cancer Science & Therapy September 10-12, 2012 San Antonio, USA

International Conference and Exhibition on Biowaivers and Biosimilars September 10-12, 2012 San Antonio, TX, USA

International Conference on Central Nervous System September 5-7, 2012 Double by Hilton Philadephia, USA.

International Conference on Occupational Health and Safety Summit September 5-7, 2012 Philadelphia, USA

International Conference and Exhibition on pathology August 27-29, 2012 Philadelphia, USA

International Conference and Exhibition on Nutritional Science & Therapy-2012 August 27-29, 2012 Philadelphia, USA

International Conference and Exhibition on Addiction Research & Therapy Aug 20-22, 2012 Las Vegas, USA

2nd World Congress on Virology Aug 20-22, 2012 Las Vegas, USA

International Conference and Exhibition on Nephrology and Therapeutics August 20-22, 2012, Chicago Chicago, USA

2nd International Conference on Vaccines & Vaccination August 20-22, 2012 at Chicago, USA.

World Congress on Earth Science & Climate Change 21–22 Aug 2012, Chicago, USA 20-22 Aug 2012 Las Vegas, USA

International Conference and Exhibition on Orthopedics Aug 13th–15th, 2012 Chicago, USA

International Conference and Exhibition on Rheumatology and Therapeutics Aug 14–15, 2012 at Chicago, USA

3rd International Conference on Biomarkers & Clinical Research July 2-4, 2012 Las Vegas, USA

2nd International Conference on Proteomics & Bioinformatics July 2-4, 2012 Las Vegas, USA

International Conference and Exhibition on Neurology & Therapeutics May 14-16, 2012 Las Vegas, USA

International Conference and Exhibition on Biosensors & Bioelectronics May 14-16, 2012 Las Vegas, USA.

3rd World Congress on Bioavailability & Bioequivalence: Pharmaceutical R & D Summit March 26-28, 2012 Marriott Hotel, Hyderabad, India

International Conference & Exhibition on Nanotechnology and Nanomedicine March 12-14, 2012 Omaha, USA

World Congress on Gastroenterology and Urology March 12-14, 2012 Omaha, USA

International Conference & Exhibition on Biometrics & Biostatistics March 5-7, 2012 Omaha, USA

2nd World Congress on Clinical & Experimental Dermatology March 5-7, 2012 Omaha Marriott, USA

2nd World Congress on Clinical & Experimental Cardiology March 5-7, 2012 Omaha Marriott, USA

2nd World Congress on Clinical & Experimental Ophthalmology March 5-7, 2012 Omaha Marriott, USA

International Conference and Exhibition on Metabolomics & Systems Biology February 20-22, 2012 San Francisco, USA

2nd World Congress on Pharmaceutics & Novel Drug Delivery Systems February 20-22, 2012 San Francisco, USA

2nd world Congress on Analytical and Bioanalytical Techniques 16-17 December 2011San franscico, USA.

2nd World Congress on Diabetes & Metabolism 6-8 December 2011 Philadelphia, USA.

International Conference on Pediatrics & Gynecology 6-8 December 2011 Philadelphia, USA.

International Conference and Exhibition on Cell Science & Stem Cell Research 29 Nov-1 Dec 2011 Philadelphia, USA.

2nd World Congress on Biotechnology 29 Nov -1 Dec 2011 Philadelphia, USA.

International Conference and Exhibition on Vaccines & Vaccination 22-24 November 2011 Philadelphia, USA.

2nd World Congress on Biomarkers & Clinical Research 12-14 September 2011 Baltimore, USA.

International Conference and Exhibition on Virology 5-7 September 2011 Baltimore, USA.

International Conference and Exhibition on Pharmaceutical Regulatory Affairs 6-7 September 2011 Baltimore, USA.

International Conference and Exhibition on Cancer Science & Therapy 15-17 August 2011 Las Vegas, USA.

International Conference on Clinical Research: Dermatology, Ophthalmology and Cardiology 5-6 July 2011 San Francisco, USA.

International Conference & Exhibition on Proteomics & Bioinformatics 6-8 June 2011 HICC, Hyderabad, India.

International Conference & Exhibition on Pharmaceutical Biotechnology 6-8 June 2011 HICC, Hyderabad, India.

2nd World Congress on Bioavailability & Bioequivalence: Pharmaceutical R & D Summit 6-8 June 2011 Las Vegas, USA.

International Conference on Pharmaceutics & Novel Drug Delivery Systems 7-8 June Las Vegas, USA.

World Congress on Biotechnology 21-23 March 2011 Hyderabad, India.

International Conference on Diabetes and Metabolism 13-14 December 2010 Santa Clara, USA.

International Conference on Biomarkers & Clinical Research 22-23 November 2010 Santa Clara, USA

International Conference and Exhibition on Analytical and Bioanalytical Techniques: Pharmaceutical R & D Summit 01 - 03 November 2010 Hyderabad, India

International Conference & Exhibition on Bioequivalence & Bioavailability 2010, Pharmaceutical R & D Summit March 01-03, 2010.

Integrating Glycomics with other Omics in Cancer Detection and Diagnosis, January 19-20, 2010, Stanford University School of Medicine.

3rd World Congress of Gene-2009, December 1-7, 2009.

7th Annual World Congress of International Drug Discovery Science & Technology, October 22-25.

2nd WSA-2009, July 18-20, 2009

1st CCSB-2009, February 16-17, 2009

2nd PRICPS-4th AOHUPO, June 22-26, 2008

95th ISCA, January 5-8, 2008
Open Access PublicationsOpen Access Journals listInternational Scientific Conferences

Search :     Advanced Search 

Home   |   Join   |   Contact     

     
 
Review Article Open Access
 
Security in a Goldfish Bowl: the NSABB’s Exacerbation of the Bioterrorism Threat
Research Scientist, Butterfly Sciences, USA Brian P. Hanley*
 
Corresponding Author : Brian P. Hanley
Research Scientist
Butterfly Sciences, USA
Tel: 415-518-8153
E-mail: brian.paul.hanley@gmail.com
 
Received January 05, 2013; Accepted February 19, 2013; Published February 25, 2013
 
Citation: Hanley BP (2013) Security in a Goldfish Bowl: the NSABB’s Exacerbation of the Bioterrorism Threat. J Bioterr Biodef S3:013. doi: 10.4172/2157-2526.S3-013
 
Copyright: © 2013 Byers RJ, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
 
Related article at
DownloadPubmed DownloadScholar Google
 
 
Abstract
 

If our potential adversaries are understood, publicity drawing the attention of bioterrorists to plausible bioweapons is the primary contribution the NSABB makes by censorship recommendations. Attempting censorship by attracting the entire world’s attention to information of concern is obviously counterproductive.
It is equally problematic to curb research in an attempt to prevent those outside our borders from understanding how to create bioweapons. That horse is, “Out of the barn and in the next county”. Locking the barn door is not going to change this. Proliferation of molecular biology, vaccine and other knowledge across the world has already taken place. Thus, the best course is to make sure that we understand what human bioterrorists could do as well as we understand what nature can do. To date, nature has been the worst bioterrorist, but in theory human engineering can be worse.
Medicine is biodefense. The focus needs to be on response capability and surveillance, just as in any other infectious disease control. Attempting to track, outwit or contain terrorists should be left to clandestine intelligence services that are equipped to understand and interdict them. Perhaps it is true that such capabilities in our clandestine services are poorly developed or directed. The remedy for that, though, is to work to improve matters by prodding politicians rather than operate independently in attempts at interdiction that may be counterproductive. Science, law enforcement, the military and intelligence services need to work together and understand each other’s appropriate roles.

 
Introduction
 
“... we only became aware of them (biological weapons), when the enemy drew our attention to them by repeatedly expressing concerns that they can be produced simply with easily available materials....”
 
     al Zawahiri internal memorandum, April 15, 1999 [1]
 
In considering policy relative to Dual Use Research, (DUR), the record of academic analyses of the USSR serves as a warning to those in other fields. Sovietology missed predicting the USSR’s breakup and virtually every major event of the cold war [2]. We cannot allow something similar to happen in biodefense. This is doubly important because bioscience and medicine are the “armed forces” that understand the technology and how to use it. But there are other, ‘soft factors’ that are critical to understand – motivations, group dynamics, strategy, capability, ideology, enough empathy to get inside the enemy’s head without becoming sympathetic, and enough humility to know when one is out of one’s depth in the arena of ‘soft factors’.
 
Information dissemination into and through societies across the globe, methods and motivations of violent actors, current events, and understanding of strategic advantage are not scientific matters. However, without understanding and using such materials, it is impossible to provide an intelligent discussion of the national security matter that is bioterrorism. Thus, for scientists to have a meaningful role in national security policy matters requires study and logical inference outside of the realm of hard science.
 
It follows that to make a useful contribution to the question of DUR, this paper makes use of such materials and inference.
 
Bioweapons in the USSR
 
The USSR created a sophisticated bioweapons program with an attack protocol that would follow up nuclear missiles with ICBM delivery of organisms such as engineered smallpox-ebola and multidrug resistant plague. The object was to further decimate weakened populations [3].
 
As documented by the former second in command of the USSR’s Biopreparat program, using the simple method of lying, this program evaded the Biological and Toxin Weapons Convention (BWC) of 19721. The existence of the 1972 treaty created a barrier to all other signatories, thus conferring a strategic military advantage2. Whether the entire Biopreparat (Биопрепарат) weapons program was shut down when the USSR transitioned to the Russian Federation is an open question3.
 
Open and closed societies
 
The history of the USSR bioweapons program highlights the difference in functioning that a rule of law, open society nation has from closed society nations [4]. The former is exampled by the functioning democracies in the developed world, of which the United States is a member. In an open society, most matters are discussed and settled openly, and transparency is positively valued. In the United States, freedom of the press is in our constitution and we have tools such as the freedom of information act to enforce governmental transparency.
 
Closed society is exemplified by dictatorships, quasi-dictatorships and military juntas around the world. Closed societies are totalitarian, secretive, and use oppression to suppress opponents. North Korea is the most outstanding example of a closed society in the world today. It is a totalitarian state that has large prison camps containing multiple generations of political prisoners, and practices torture, even over minor matters [5].
 
Violent non-state actors
 
In today’s world, violent non-state actors (VNSAs) must be added to this equation. VNSA is an acronym used by the military to describe persons, groups and movements engaged in asymmetric warfare that are not identified with a nation-state [6,7]. Asymmetric warfare is a term for methods and strategy used by militarily weaker parties to do battle with a conventionally stronger adversary. Guerilla warfare is a classic example of a form of asymmetric conflict. What we loosely call terrorists are also VNSAs.
 
Dual use research
 
Concerns about potential dangers of recombinant DNA originated prior to the Asilomar conference of 1975. The Asilomar conference formalized the first set of guidelines on genetic engineering [8]. Early scientific concerns about recombinant DNA evolved into applying the established concept of dual-use technology for nuclear weapons to biology [9,10]. After the publication of polio synthesis and the IL-4 mousepox papers, scientists became concerned about dual use research (DUR) that could be used for weapons [10]. It has been ten years since the CIA formally stated that biologically engineered disease could be worse than any natural disease [11]. DUR in biosciences and what to do about it has been a topic of discussion for over a decade.
 
VNSA use of bioweapons
 
That VNSAs have obtained and deployed biological weapons has been a concern for some time [12]. Two VNSAs4, the Aum cult and the security chief5 of the Rajneesh organization, have done so, although their attempts at deployment created no known mortality from biological weapons [13,14]. The Aum cult’s leader drove weapons acquisition, but it was the Rajneesh group’s leader who blew the whistle to authorities when he found out what Anand Sheela had done [15].
 
In the current era, Al Qaeda6 has stated its interest in Chemical and Biological Weapons (CBW) and made attempts to pursue them [1].
 
NSABB legal authorities
 
Today, the National Science Advisory Board for Biosecurity (NSABB) reviews scientific research papers for DUR developments. The authority for the NSABB is based in an amendment to 42 U.S.c. 217a, section 222 of the Public Health Service Act, and Public Law 109- 417, section 205 of the Pandemic and All-Hazards and Preparedness Act [16]. Those relevant sections state:
 
42 § 217a. Advisory Councils or Committees
(a)Appointment; purpose
The Secretary may, without regard to the provisions of title 5 governing appointments in the competitive service, and without regard to the provisions of chapter 51 and subchapter III of chapter 53 of such title relating to classification and General Schedule pay rates, from time to time, appoint such advisory councils or committees (in addition to those authorized to be established under other provisions of law), for such periods of time, as he deems desirable with such period commencing on a date specified by the Secretary for the purpose of advising him in connection with any of his functions [17].
SEC. 205. National Science Advisory Board for Biosecurity
     The National Science Advisory Board for Biosecurity shall, when requested by the Secretary of Health and Human Services, provide to relevant Federal departments and agencies, advice, guidance, or recommendations concerning--
          (1) A core curriculum and training requirements for workers in maximum containment biological laboratories; and
          (2) Periodic evaluations of maximum containment biological laboratory capacity nationwide and assessments of the future need for increased laboratory capacity [18].
 
       The White House web site states regarding the NSABB, “The NSABB is charged with advising on ways to minimize the possibility that information and technologies emanating from vitally important biological research might be misused to threaten public health or other aspects of national security” [19].
 
Formal authority of the NSABB to make recommendations to censor scientific publications appears to be voluntary under the law although other authorities may exist based on prevention of public health disaster [20]. Leaving that question aside, the fundamental premise of the NSABB is that it is intended to improve security and public health. The major question of this article is whether security is improved when the NSABB censors material.
 
First test case – Fouchier and Kawaoka
 
The first major test case was the H5N1 work of Fouchier and Kawaoka which was eventually published [21,22]. The NSABB issued a recommendation on 20th of December, 2011 recommending that some elements of the papers be withheld [23]. This created a media firestorm that persisted for months. The WHO disagreed, and the NIH requested an appeal. The NSABB reversed itself March 30th of 2012 [24]. Press coverage of the “killer virus” was extensive for months afterward. Investigations have resumed in 2013 [25].
 
Medicine’s needs in order to respond
 
The primary need of medicine is the dissemination of accurate information that allows optimum, timely response to disease. Historically, bioscience has provided openly communicated literature and done its best to educate physicians. This need of medicine for openly communicated information is in opposition to the interests of secrecy that seeks to prevent dissemination of DUR. Since in a basic sense, most of medicine and science is potentially applicable to terminating as well as saving human life, the question of where to draw a line is thorny.
 
This question of where to draw a line on secrecy is complicated by a little discussed matter. In an open society, is it possible to debate such matters – without simultaneously informing interested parties what they should try?
 
The Goldfish Bowl
 
Some in social sciences study the role of the media in armed conflict [26,27]. However, scientists generally have little education and experience in media [28,29].
 
Political sensitivity to frightening stories is shown in the passage of the Pandemic and All Hazards Preparedness Act which created the NSABB [18]. A basic rule of news media is – if people can die, people are dying or people are dead, that will get prominent coverage unless it is overshadowed by greater carnage7 or a culturally more sympathetic story [30,31]. This tendency of the news media has strong effects on viewers [32].
 
Stories capable of moving Stories about carnage or potential mass death of American citizens off the front page8 are rare. A classic example of overshadowing (albeit where civilian US citizens were not threatened) can be seen in the “Olympics War” in the Republic of Georgia in 2008 [33]. Because of the more sympathetic story of Michael Phelps and other Olympians, there was little coverage. However, news organizations did travel there, and geared up for covering a war – but the conflict terminated a day prior to the Olympics closing, and it began during the opening ceremony in Beijing.
 
Lacking good public relations cover, the NSABB’s censorship recommendations on a virus plausibly deadly to millions of Americans is irresistible news media fodder. This irresistibility is made even more intractable by the long period of time that such a story is live. Nothing in science is over and done in a week or two, so it would take an extraordinary overshadowing event or series of them to prevent news media from reporting on a disease potentially deadly to millions of people.
 
The NSABB’s censorship recommendations will always contain threat of mass death coupled with the threat being aimed at the USA’s citizens. If there is no such threat, why would the NSABB recommend censorship? Thus, it is inevitable that media outlets will thoroughly report such stories. Science journalists, at least, understand this implicitly, as shown by headlines on the NSABB censorship [34]. In an open society, there is no way to prevent it.
 
Today virtually everyone in the world has access to television, the internet, or cell phone messaging/data to get news. Internet access in the developing world was 20.5% in 2011, with mobile internet services surging; 29% of Arab states population is estimated to use the internet, although the spread is wide, correlating with per capita income [35]. Cell phone subscriptions worldwide hit 6 billion in 2011, with 600 million new subscriptions that year, mostly in the developing world; as of 2011, there were 778 developing world cell phone subscriptions per thousand people [35]. CNN and other Western television channels were widely available through direct broadcast in the middle-east 16 years ago [36]. News organizations today are globally networked and direct western channels such as CNN and BBC have global reach [37]. Where Western news services do not directly penetrate, local ones such as RT and Al Jazeera9 do. The NSABB story was distributed on the web sites of Al Jazeera and RT (Novosti) [38-40].
 
VNSAs sworn to make war on the United States use the internet to gather actionable intelligence [41]. Thus, it follows that whenever the news media are prompted to give front page coverage to a story, that story is seen or reported indirectly to VNSAs and they make use of it for war making purposes [1].
 
In the USA, news media historically provide little coverage of events beyond our shores [42]. Conversely, news events in the USA take place in the equivalent of a department store window, as this country is considered a major source of news [42]. This tends to result in naïve actions on the part of concerned scientists and citizens who may presume that other nations have as little attention for the USA as we do for them. This is illustrated well by the 1999 Al Zawahiri memo [1].
 
Using the Wrong Criteria for Assessment Due to Weak Scenario Building
 
The NSABB originally decided that details useful to synthesis of the H5N1 virus passaged in ferrets should be kept secret, indicating concern about synthetic production of the virus in sophisticated laboratories.
 
This decision appears to have been taken without considering the strategic environment of terrorists seeking biological weapons, nor mapping out scenarios. Scenario building and capability assessment is fundamental to such policy decisions; or it should be [43]. To set up scenarios, it is necessary to think about who the adversaries are and how they would operate. The discussion here is of necessity an overview of a nuanced topic, provided for orientation purposes.
 
Overview of VNSAs
 
Being a VNSA can be extremely lucrative at the top, netting hundreds of millions of dollars tax free [44]. A common evolution of VNSAs is to become proxies for the interests of a nation state which supports the VNSA with money and weapons. What the client state wants is effectiveness pursuing some foreign or domestic policy objective. A state engaging in proxy warfare does not need more than a handful of its own people involved, a relatively small budget and does not risk war on its own territory. Proxy war and saber rattling excuse a lot of domestic failures and this is the cheapest and safest kind of war for a state to engage in understanding and countering the motives and methods of warlords [45].
 
The USA used proxies in Afghanistan against the USSR’s occupation [46]. And just as with rogue states supporting proxies, a huge amount of money was stolen from us as we supported the precursors to today’s Taliban10 against the Soviets [47].
 
Interest in bioweapons
 
More problematic VNSAs are independent idealists such as Osama bin Laden and the rest of Al Qaeda. Their money can come from control of resources such as diamond fields or drug trade [48], or it can come from contributions of wealthy donors or through front organizations [49]. Of these VNSAs, the religious fanatic has been the most worrisome. It is true that past performance is no guarantee of future results in terrorism, but biological warfare in the past 40 years has, with the exception of the USSR, South Africa, Iraq, and possibly France [3,15], been pursued by religious fanatics both domestic and foreign [13,14]. VNSAs are the sole parties known to have deployed them since WWII, so this type should be considered carefully11. In addition to foreign, domestic actors should be considered, both because of trans-national recruitment and other groups (viz. Asahara’s direction of the Aum cult and Rajneesh’s rogue security).
 
Budget levels
 
The 9-11 attacks cost Al Qaeda on the order of $500,000 to pull off [50]. In 1999, al Zawahiri provided $2000 - $4000 for anthrax development [1]. Higher budget operations than 9-11 are certainly possible, but a budget on the order of $500,000 is reasonable, removing costs of such things as regulatory compliance from the scenario. As well, lower budgets should be considered.
 
Education
 
Education is sometimes raised as a barrier, and it probably is significant. However, education and skills barriers are slowly falling, with private parties doing molecular biology as a hobby in the USA [51]. In the middle east are many excellent universities with ambitions to perform research [52], although bioscience research is still weak [53]. But even the not so well educated can be interested in bioweapons. I have personally fielded a request for directions on how to culture rabies from a party believed to be in Pakistan that was obviously ignorant. While anecdotal, it does suggest a continuing interest in biological weapons even in the less educated.
 
Physicians are present in the ranks of current VNSAs despite the Hippocratic Oath. The number two man in Al Qaeda, Ayman al- Zawahiri was a physician [54]. The terrorist cell in England that placed two car bombs was composed of physicians [55]. A UK National Health Service doctor on sabbatical in Syria kidnapped and shot a journalist this summer [56]. The obvious implication is that presence in the club of colleagues does not exempt someone from potentially being a VNSA.
 
However, many physicians probably lack the necessary skills to perform gene synthesis, recombinant engineering, or cell culture and virus culture. At minimum, the latter skills are needed for bioweapons development, and the former are required for advanced bioweapons. That said, personal experience has connected me with researchers in vaccinology all over the world, and vaccinology develops skill sets that transfer well to bioweapons development.
 
Simple scenarios
 
A poorly financed but sufficiently educated VNSA looking at the Fouchier and Kawaoka H5N1 papers would be most intrigued by the passaging method. This method appears in early news stories about their work. It also appears in other easily available open sources such as Laurie Garret’s past work. Passaging is a method that could be applied using caves or tents and prisoners after immunizing the production team with low tech vaccine. The cost would be low, only marginally above the cost of maintaining a guerilla camp. Dispersal could be done using martyr-seeking volunteers traveling on commercial aircraft or perhaps using slightly more sophisticated methods.
 
A well financed VNSA with lab facilities capable of advanced DNA sequence synthesis would most likely already have a plan in process. Even terrorists are unlikely to finance laboratories without some plan for what they will do with them. (In 1999, al Zawahiri parted with $2000 - $4000 [1].) To get the funding necessary to build a sophisticated lab, it would be necessary to make promises for delivery. Even with cheap equipment acquired second-hand, cost of supplies and premises will be significant, as is the learning curve. Thus, a product, or a set of products, would be expected to be planned from the outset. There are also quite a few potential organisms other than H5N1 that could serve the purpose of terrorist attack at least as well.
 
Since smallpox, the 1917 influenza virus and other sequences are already in public domain; those with access to sophisticated facilities should be able to generate them. Such VNSAs could also create something along the lines of the USSR’s smallpox-ebola virus12. A little bribery, or a few key infiltrators into a commercial facility and there it is. Alternatively, a well financed effort could build a state of the art facility, or owners of one could be sympathetic enough to allow its use for the VNSA war making effort. Considering these points, it becomes clear that while an H5N1 that was highly contagious and lethal could be of interest, most likely any such facility would already have worse plans.
 
Weaponizable organisms can also be collected from the field and cultured by people who obtain equipment. In an exercise, I put together equipment, exclusive of supplies and premises, for such a lab for under $10,000. Anthrax is endemic to the developing world where many VNSAs make their home [57]. It is easily collected in the field and can be cultured in materials available to agrarian people.
 
Biosafety standards have their roots in Ft. Detrick work from 1944- 1969 and the CDC first published the 4 level biosafety advisory in 1974 [58]. Prior to the middle of the 20th century, what we now consider
BSL-4 organisms were mostly handled with standard lab bench-top methods. It was accidents of transmission that resulted in changing such practices. Even as late as 2003, standards for things like transport were fuzzy, as illustrated by the Butler case [59]. There is no reason why bioweapons seeking VNSAs can’t use less safe bench-top methods of yesteryear13.
 
The Current NIH Proposal
 
Currently, the NIH is floating a proposal to the NSABB regarding what would or would not get funded [60]. The implicit idea behind not funding certain research is that it will make citizens safer. However, this concept has significant issues. It is founded in two assumptions: That adversaries would not perform effective work of their own (in a time when biotechnology and molecular biology capability has spread across the globe); and that the benefits of censorship outweigh the benefit of medicine (e.g. biodefense) being fully informed about a possible threat.
 
In the case of the Fouchier and Kawaoka H5N1 work, nature could generate a similar virus – that was the reason for the effort in the first place. Since scientists should be informed about what changes to look for in a more easily transmitted version, it makes sense that such research be done. A similar argument applies to understanding what an adversary could deliberately engineer, although the latter is more subject to debate.
 
Effective Interdiction of Bioterrorism
 
What we all want is to maximize public safety. Any proposition that censorship of DUR is, or could be, an effective method of interdiction of bioterrorism needs to be thoroughly justified.
 
Other methods of interdiction do have significant merit. For instance:
 
“…identify and observe non-state actors that have apocalyptic prophecies, confront local authorities and recruit people with advanced degrees”.
 
“…monitor the purchases of materials connected with chemical or biological agents and to identify groups that seek information about WMD”.
 
“… develop methods for detecting WMD use during the research and development stages” [12].
 
To that list, I would add that bioscientists should be alert to the possible presence of persons sympathetic with bioterrorism in their university laboratories. It is illogical to presume that they are not present.
 
Conclusion
 
The net result of the NSABB’s censorship recommendations was to shout in the ears of our enemies precisely what the NSABB did not want them to find out. The papers that received censorship recommendations would have likely vanished into the ocean of scientific publications without being noticed if left alone. Thus, the NSABB action represents a ‘Potemkin perimeter’ – undertaken to create the impression of protection that does not do so.
 
The NSABB needs to clearly explain how VNSAs who do read scientific journals could be prevented from creating bioweapons by such minor acts of censorship as the Fouchier and Kawaoka papers – even if it were possible to execute such censorship in absolute secrecy. There are so many ways to approach creating bioweapons that, realistically, it is not credible that another drop added to the ocean of science [61] could make a difference. Once that is explained, the NSABB needs to explain how censorship benefits society after adding the factor that every possible inimical party will always be informed of what is censored – because we live in an open society.
 
Even if censorship could be implemented while preserving secrecy about the topic of censorship, how realistic is it to believe that universities can safeguard such information from VNSA agents who target it by going to the university? University professors do not have the training, legal authority nor inclination to implement operational security (OPSEC) effectively. Additionally, students have rights and can claim to be discriminated against in an open society. If censorship were implemented, that would make the information that much more valuable to a bioterrorist (assuming it really matters) because medical response personnel would generally be unaware of it. This would represent, on a small scale, the same kind of strategic advantage that the USSR gained by moving ahead under cover of the BWC.
 
Our primary requirements to safeguard public health against bioterrorism (and natural epidemics) are detection and response capability. That capability is best served by dissemination of all research information so that there is no problem with diagnostics, surveillance, or tracking of any conceivable disease.
 
We need to remember that it was an alert physician who diagnosed the anthrax letter attack. What we must do is ensure that every physician knows as much as possible about biological warfare. That will protect us. Censorship of science is a lost cause and should be abandoned.
 
The record of the incidents in Oregon shows that it was scientists striving to avoid appearing bigoted toward Rajneesh who stopped that investigation, and authorities took a similar veering approach in Japan toward Aum [12,15]. One hopes that things have changed in today’s world. However, scientists learn to require outstanding degrees of proof before accepting a proposition as fact. That posture is very different from the intelligence collection methodology that collects possible signs and weighs them as probabilities against scenarios. Thus, scientists should attempt to act in concert with intelligence and police agencies rather than working independently to interdict VNSAs. Scientists, who wish to be active, should educate themselves far outside their specialties in order to make a positive impact on bioterrorism.
 
1This book, ‘Biohazard: The Chilling True Story of the Largest Covert Biological Weapons Program in the World--Told from Inside by the Man Who Ran It’ is required reading for anyone purporting expertise in bioweapons policy.
 
2I am well aware that the 1972 convention is a sacred cow among a great many scientists and activists. That status implicitly proposes that since the treaty was well intended, and it would have worked if everyone had obeyed it, it must have accomplished good. That logic is prima facie fallacious.
 
3Given the record, Occam’s razor says that prevarication and dissembling should be assumed by the Russian Federation. However, rendering an opinion on the matter, I don’t think a Russian Federation bioweapons program is militarily significant to the rest of the world regardless its status. State actors have severe strategic limitations on use due to blowback and retaliation concerns that VNSAs do not have.
 
4I am leaving out the use of a bioweapon by organized crime in Moscow, Russia, that is described by Ken Alibek in ‘Biohazard.’ That incident was a mafia hit without a political component or attack on ordinary citizens required to class it as a VNSA conducting asymmetric warfare. Making that distinction does illustrate the gray areas of bioterrorism.
 
5There are indications that the Rajneesh cult incidents were entangled with an embezzlement scheme by the security chief, Anand Sheela. She handled money for the group and left it with a $55 million debt. After evading pickup in a mix-up of dates of her release from prison, she made her way to Switzerland and purchased a chain of hospitals.
 
6I will leave aside the issue of what, exactly; Al Qaeda is – whether it is a loose association or a distinct entity with formal command structure. Discussing the subtleties of this and its relationship to Wahabbism, Sayyid Qtub’s “In the Shade of the Qu’ran”, and the Muslim Brotherhood, is far too complex to do here. For the purposes of this paper, the precise structure has minor bearing on interest in or capability of delivering bioweapons.
 
7The largest land battle in world history occurred between Eritrea and Ethiopia during the Kosovo campaign. Western media were silent and few know it even happened.
 
8Front page is used metaphorically here. It includes prominent placement of stories on TV, news web sites, blogs, etc.
 
9Al Jazeera is controlled by Qatar’s emir. This probably makes it more temperate and aware of the impact of news stories such as the influenza story than Western channels, since Qatar is generally friendly to Western powers.
 
10The USA during the Soviet occupation of Afghanistan made payments and supplied materiel to the Pakistani government. The Pakistani government in the present era could not find Osama bin Laden in the middle of Abbottabad while we paid them more billions.
 
11The Amerithrax case is probably Ivins, a scientist, but not conclusively nailed down. Scientists and colleagues as VNSAs are, however, to be expected. Drawing a sharp line between state and non-state actors is justified because the motivations, concerns over blowback, war making effects and effectiveness, and vulnerability to military retaliation and sanctions for state actors is very different. Details of that are far too involved to more than mention here.
 
12Generally speaking, gene synthesis companies in the USA are fairly likely to detect and flag requests for DNA known to be potentially inimical. However, obviously, lab staff could produce them without anyone being the wiser. Outside our borders, it would be even easier.
 
13Not using good biocontainment practices would be helpful to detection of clandestine facilities. However, detection when incidents occur requires that authorities and epidemiologists be alert. Japanese authorities and scientists turned a blind eye to the Matsumoto sarin ‘accident’, and to the spraying of attenuated anthrax off a roof in Tokyo. American scientists turned a blind eye to the salmonella incident in Oregon.
 
References
 





























































 


 View 

 Download    pdf version of this article

References






























































Select your language of interest to view the total content in your interested language
 
Share This Article
   
 
   
 
About JBTBD
Download Journal Home
Download Editorial Board Members
Download Current Issue
Download Previous Issue
Download Archive
Download Instructions for Authors
Download Submit Manuscript
Download Contact Editorial Office
 
Article usage
  Total views: 10533
  [From(publication date):
specialissue-2013- Aug 27, 2014]
  Breakdown by view type
  HTML page views : 6810
  PDF downloads :3723
 
Article Tools
Download Export citation
Download Share/Blog this article
Download Recommend to your Librarian
 
 
Special Features
Download Download PDF
Download Digital File
Download Listen Audio
Download Download Audio